Collagen Vascular Diseases

  • Martina BonifaziEmail author
  • Francesca Barbisan
  • Stefani Gasparini


The spectrum of connective tissue diseases (CTDs) includes a heterogeneous group of disorders characterized by circulating autoantibodies and organ-specific autoimmune injuries, leading to variable systemic manifestations. Diffuse parenchymal lung diseases (DPLDs) are the most common pulmonary manifestation, and a baseline assessment of morphological patterns and ongoing pathogenic activity have relevant implications in terms of prognostic estimates and therapeutic management. Moreover, in some cases, when clinical, serological, or morphological features do not meet criteria for a specific rheumatic disease, tissue acquisition gains, even more, a relevant role, as the identification of morphological pattern is crucial to estimate patient prognosis and guide management.


Collagen vascular diseases Transbronchial lung cryobiopsy Anti-synthetase syndrome Rheumatoid arthritis Sjögren syndrome Diagnosis 


  1. 1.
    Doyle TJ, Dellaripa PF. Lung manifestations in the rheumatic diseases. Chest. 2017;152(6):1283–95.CrossRefGoogle Scholar
  2. 2.
    Kinder BW, Shariat C, Collard HR, et al. Undifferentiated connective tissue disease-associated interstitial lung disease: changes in lung function. Lung. 2010;188(2):143–9.CrossRefGoogle Scholar
  3. 3.
    Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46(4):976–87.CrossRefGoogle Scholar
  4. 4.
    Gofrit SG, Yonath H, Lidar M, et al. The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders. Clin Rheumatol. 2018;37(5):1257–63.CrossRefGoogle Scholar
  5. 5.
    Chatterjee S, Prayson R, Farver C. Antisynthetase syndrome: not just an inflammatory myopathy. Cleve Clin J Med. 2013;80(10):655–66.CrossRefGoogle Scholar
  6. 6.
    Wight EC, Baqir M, Ryu JH. Constrictive bronchiolitis in patients with primary Sjögren syndrome. J clin Rheumatol. 2019;25(2):74–7.PubMedGoogle Scholar
  7. 7.
    Roca F, Dominique S, Schmidt J, et al. Interstitial lung disease in primary Sjögren’s syndrome. Autoimmun Rev. 2017;16(1):48–54.CrossRefGoogle Scholar
  8. 8.
    Lynch DA, Sverzellati N, Travis WD. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018;6(2):138–53.CrossRefGoogle Scholar
  9. 9.
    Paulin F, Doyle TJ, Fletcher EA, et al. Rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis: shared mechanistic and phenotypic traits suggest overlapping disease mechanisms. Rev Investig Clin. 2015;67(5):280–6.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Martina Bonifazi
    • 1
    • 2
    Email author
  • Francesca Barbisan
    • 3
  • Stefani Gasparini
    • 1
    • 2
  1. 1.Department of Biomedical Sciences and Public HealthUniversità Politecnica delle MarcheAnconaItaly
  2. 2.Pulmonary Diseases UnitAzienda Ospedali RiunitiAnconaItaly
  3. 3.Pathologic Anatomy UnitAzienda Ospedali RiunitiAnconaItaly

Personalised recommendations